Literature DB >> 2173824

Binding sites in mammalian genes and viral gene regulatory regions recognized by methylated DNA-binding protein.

X Y Zhang1, C K Asiedu, P C Supakar, R Khan, K C Ehrlich, M Ehrlich.   

Abstract

Methylated DNA-binding protein (MDBP), a ubiquitous mammalian protein, recognizes a variety of related DNA sequences. Some of these sequences require methylation of their CpG dinucleotides for binding and others do not. We report that MDBP binds, in a DNA methylation-independent fashion, to two sites in the mouse polyomavirus enhancer, one in the enhancer of the human hepatitis B virus, and to one in the long terminal repeat of equine infectious anemia proviral DNA. We have also found a number of MDBP sites in human and rodent DNAs which bind much better to MDBP when they are methylated at CpG dinucleotides within the recognition site. These include sites at the beginning of the human genes for hypoxanthine phosphoribosyl transferase, HLA-A2, -A3, and -A25 antigens, and alpha-galactosidase A. In the case of methylation-responsive MDBP sites, changes in their methylation status during differentiation or DNA replication could help drive development by modulating transcription.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173824      PMCID: PMC332489          DOI: 10.1093/nar/18.21.6253

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  48 in total

Review 1.  Modularity in promoters and enhancers.

Authors:  W S Dynan
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  How different DNA sequences are recognized by a DNA-binding protein: effects of partial proteolysis.

Authors:  P C Supakar; X Y Zhang; S Githens; R Khan; K C Ehrlich; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

3.  Highly repeated sites in the apolipoprotein(a) gene recognized by methylated DNA-binding protein, a sequence-specific DNA-binding protein.

Authors:  K C Ehrlich; M Ehrlich
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

4.  Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region.

Authors:  P Ostapchuk; G Scheirle; P Hearing
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

5.  Structure of gene and pseudogenes of human apoferritin H.

Authors:  F Costanzo; M Colombo; S Staempfli; C Santoro; M Marone; R Frank; H Delius; R Cortese
Journal:  Nucleic Acids Res       Date:  1986-01-24       Impact factor: 16.971

6.  Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification.

Authors:  P D Ennis; J Zemmour; R D Salter; P Parham
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

7.  Cellular factors that interact with the hepatitis B virus enhancer.

Authors:  R Ben-Levy; O Faktor; I Berger; Y Shaul
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

8.  The organization of the human HPRT gene.

Authors:  S H Kim; J C Moores; D David; J G Respess; D J Jolly; T Friedmann
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

9.  Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice.

Authors:  R Rochford; B A Campbell; L P Villarreal
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

10.  Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains.

Authors:  S Karpen; R Banerjee; A Zelent; P Price; G Acs
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

View more
  25 in total

1.  Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele.

Authors:  T F Fitzmaurice; R J Desnick; D F Bishop
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Differential binding of human nuclear proteins to Alu subfamilies.

Authors:  N V Tomilin; V M Bozhkov; E M Bradbury; C W Schmid
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

Review 3.  Biological aspects of cytosine methylation in eukaryotic cells.

Authors:  M Hergersberg
Journal:  Experientia       Date:  1991-12-01

4.  Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human α-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians.

Authors:  J P Oliveira; S Ferreira; J Barceló; P Gaspar; F Carvalho; M C Sá Miranda; J-E Månsson
Journal:  J Inherit Metab Dis       Date:  2008-11-03       Impact factor: 4.982

5.  Inactive chromatin spreads from a focus of methylation.

Authors:  S U Kass; J P Goddard; R L Adams
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities.

Authors:  Y Katan; R Agami; Y Shaul
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

Review 7.  Transcription factors as readers and effectors of DNA methylation.

Authors:  Heng Zhu; Guohua Wang; Jiang Qian
Journal:  Nat Rev Genet       Date:  2016-08-01       Impact factor: 53.242

8.  Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition.

Authors:  I Vorechovský; A D Webster; A Plebani; L Hammarström
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 9.  The evolution of small DNA viruses of eukaryotes: past and present considerations.

Authors:  F F Shadan; L P Villarreal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

10.  Phosphorylation of MRF4 transactivation domain by p38 mediates repression of specific myogenic genes.

Authors:  Mònica Suelves; Frederic Lluís; Vanessa Ruiz; Angel R Nebreda; Pura Muñoz-Cánoves
Journal:  EMBO J       Date:  2004-01-22       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.